Determination of prostate-specific antigen complexed to alpha2-macroglobulin in serum increases the specificity of free to total PSA for prostate cancer

Urology

Volumn 56, Issue 2, 2000, Pages 267-272

  Zhang, Wan Ming ^a   Finne, Patrik ^a   Leinonen, Jari ^a   Salo, Jaakko ^a   Stenman, Ulf Håkan ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; COMPLEX FORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN PROTEIN INTERACTION; TECHNIQUE;

AGED; ALPHA-MACROGLOBULINS; ANIMALS; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOASSAY; MACROMOLECULAR SUBSTANCES; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0033916383     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00609-9     Document Type: Article

References (30)

1. Stamey T.A., Yang N., Hay A.R., et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 317:1987;909-916.
2. Catalona W.J., Smith D.S., Ratliff T.L., et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 324:1991;1156-1161.
3. Horninger W., Reissigl A., Klocker H., et al. Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels. Prostate. 37:1998;133-137.
4. Benson M.C., Whang I.S., Olsson C.A., et al. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol. 147:1992;817-821.
5. Carter H.B., Pearson J.D., Metter E.J., et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA. 267:1992;2215-2220.
6. Oesterling J.E., Jacobsen S.J., Klee G.G., et al. Free, complexed and total serum prostate specific antigen the establishment of appropriate reference ranges for their concentrations and ratios . J Urol. 154:1995;1090-1095.
7. Stenman U.H., Leinonen J., Alfthan H., et al. A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer assay of the complex improves clinical sensitivity for cancer . Cancer Res. 51:1991;222-226.
8. Lilja H., Christensson A., Dahlen U., et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem. 37:1991;1618-1625.
9. Zhang W.M., Finne P., Leinonen J., et al. Characterization and immunological determination of the complex between prostate-specific antigen and alpha-2-macroglobulin. Clin Chem. 44:1998;2471-2479.
10. Zhang W.M., Finne P., Leinonen J., et al. Measurement of the complex between prostate-specific antigen and alpha-1-protease inhibitor in serum. Clin Chem. 45:1999;814-821.
11. Leinonen J., Lovgren T., Vornanen T., et al. Double-label time-resolved immunofluorometric assay of prostate-specific antigen and of its complex with alpha-1-antichymotrypsin. Clin Chem. 39:1993;2098-2103.
12. Christensson A., Bjork T., Nilsson O., et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J Urol. 150:1993;100-105.
13. Stenman U.H., Hakama M., Knekt P., et al. Serum concentrations of prostate specific antigen and its complex with alpha-1-antichymotrypsin before diagnosis of prostate cancer. Lancet. 344:1994;1594-1598.
14. Catalona W.J., Partin A.W., Slawin K.M., et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease a prospective multicenter clinical trial . JAMA. 279:1998;1542-1547.
15. Ganrot P.O., Nilehn J.E. Competition between plasmin and thrombin for alpha 2-macroglobulin. Clin Chim Acta. 17:1967;511-513.
16. Christensson A., Laurell C.B., Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem. 194:1990;755-763.
17. Leinonen J., Zhang W.M., Stenman U.H. Complex formation between PSA isoenzymes and protease inhibitors. J Urol. 155:1996;1099-1103.
18. Zhou A.M., Tewari P.C., Bluestein B.I., et al. Multiple forms of prostate-specific antigen in serum differences in immunorecognition by monoclonal and polyclonal assays . Clin Chem. 39:1993;2483-2491.
19. Leinonen J., Zhang W.M., Paus E., et al. Reactivity of 77 antibodies to prostate specific antibody with isoenzymes and complexes of PSA. Tumor Biol. 20:(suppl S1):1999;28-34.
20. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:1982;29-36.
21. Catalona W.J., Hudson M.A., Scardino P.T., et al. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer receiver operating characteristic curves . J Urol. 152:1994;2037-2042.
22. Birkenmeier G., Struck F., Gebhardt R. Clearance mechanism of prostate specific antigen and its complexes with alpha-2-macroglobulin and alpha-1-antichymotrypsin. J Urol. 162:1999;897-901.
23. Stenman U.H., Leinonen J., Zhang W.M., et al. Prostate-specific antigen. Semin Cancer Biol. 9:1999;83-93.
24. Oesterling J.E., Chan D.W., Epstein J.I., et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol. 139:1988;766-772.
25. Sottrup-Jensen L., Sand O., Kristensen L., et al. The alpha-macroglobulin bait region sequence diversity and localization of cleavage sites for proteinases in five mammalian alpha-macroglobulins . J Biol Chem. 264:1989;15781-15789.
26. Piironen T., Pettersson K., Suonpaa M., et al. In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha-1-antichymotrypsin in blood samples. Urology. 48:1996;81-87.
27. Arcangeli C.G., Smith D.S., Ratliff T.L., et al. Stability of serum total and free prostate specific antigen under varying storage intervals and temperatures. J Urol. 158:1997;2182-2187.
28. Zhang W.M., Leinonen J., Kalkkinen N., et al. Prostate-specific antigen forms a complex with and cleaves alpha-1-protease inhibitor in vitro. Prostate. 33:1997;87-96.
29. Watt K.W., Lee P.J.M., Timkulu T., et al. Human prostate-specific antigen structural and functional similarity with serine proteases . Proc Natl Acad Sci USA. 83:1986;3166-3170.
30. Zhang W.M., Leinonen J., Kalkkinen N., et al. Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid. Clin Chem. 41:1995;1567-1573.